A diverse portfolio with a single, common goal—long-term value creation.
From the earliest stages of a business to full commercialization and exit, Avtar partners with companies at every phase of the business cycle. Our permanent capital and ability to invest across the business lifecycle enables our partners to focus on growing their companies. This ability is evident in our portfolio companies—from a large, public, cash-flowing Amneal (where we continue to be majority owners) to Asana, a clinical-stage biopharmaceutical company involved in drug discovery and development.
- Amneal
- Aidéo Technologies
- Asana Biosciences
- Cue Health
- Envisics
- Kashiv Biosciences
- Phil
- Prolong Pharmaceuticals
Amneal Pharmaceuticals, Inc. (NYSE: AMRX) is an integrated specialty pharmaceutical company powered by a robust U.S. generics business and a growing branded business. Amneal is a global company headquartered in Bridgewater, New Jersey.
Aidéo Technologies provides artificial intelligence solutions for healthcare providers allowing automation, revenue optimization and improved accuracy in the revenue cycle management workflow.
Asana BioSciences is a clinical-stage biopharmaceutical company focused on the discovery and development of novel targeted therapies in inflammation/immunology and oncology.
Asana’s proprietary portfolio comprises multiple drug candidates, both small molecules and biologics. Its lead asset, ASN002, is an oral dual JAK/SYK inhibitor in clinical development for patients with moderate to severe atopic dermatitis and has broad development potential in other immunological diseases. Asana’s oncology leads are targeted therapies in early clinical development for patients with advanced or metastatic cancers, including melanoma, non-small cell lung cancer, colorectal cancer and other solid tumors.
Cue Health Inc. (“Cue”) is an ISO 13485 certified company focused on developing and manufacturing consumer and professional medical diagnostic products that can be used in clinical or at-home settings. Cue’s mission is to create tools that empower physicians and consumers by increasing their access to actionable health data. Cue’s first product, the Cue Health Monitoring System, is a connected diagnostic platform. The company is based in San Diego, CA.
Envisics is an innovative automotive technology company with a focus on heads up display (“HUD”) and solid-state LiDAR solutions. The company leverages its proprietary holographic technology platform to deliver best-in-class products to OEMs globally. Envisics is led by Dr. Jamie Christmas, a pioneer and thought leader in dynamic holography.
Kashiv BioSciences was created from the combination of certain Adello Biosciences assets and Kashiv Pharma. Kashiv is a fully integrated biosciences company focused on developing innovative technologies, improved medicines, and lifecycle management products with platforms in drug delivery, 505(b)(2)s, Biosimilars and NCEs. Kashiv also offers contract research and development services to pharmaceutical clients in need of formulation and analytical development expertise and/or clinical supply manufacture. Kashiv is headquartered in Bridgewater, NJ.
Phil is a B2B2C platform that connects patients, pharmacies, prescribers, and manufacturers in the specialty prescription ecosystem. Phil builds software solutions and end-to-end services to power the $320B industry. As the market faces high costs and inefficiency, Phil aims to bring meaningful changes to patient care and the economy.
Founded in 2005 and headquartered in South Plainfield, New Jersey, Prolong Pharmaceuticals, LLC specializes in the engineering of novel biologics to treat anemias, cancers, and their debilitating comorbidities by leveraging the multi-faceted core attributes of PEGylation technology. The company is led by Dr. Abraham Abuchowski, the inventor of PEGylation, one of the most successful drug delivery technologies in history, as PEGylated therapeutic agents are now believed to be responsible for more than $30 billion in drug sales worldwide.
Located in Bridgewater, New Jersey, Amneal is one of the largest and fastest growing generic pharmaceutical manufacturers in the United States. With an expanding portfolio of generic products and branded pharmaceuticals, Amneal has expanded from a private $6 million company to a public corporation with a market cap of over $4 billion.
Aidéo Technologies provides artificial intelligence solutions for healthcare providers allowing automation, revenue optimization and improved accuracy in the revenue cycle management workflow.
Asana BioSciences is a clinical-stage biopharmaceutical company focused on the discovery and development of novel targeted therapies in inflammation/immunology and oncology.
Asana’s proprietary portfolio comprises multiple drug candidates, both small molecules and biologics. Our lead asset, ASN002, is an oral dual JAK/SYK inhibitor in Phase 2b clinical development for patients with moderate to severe atopic dermatitis and has broad development potential in other immunological diseases. Our oncology leads are targeted therapies in early clinical development for patients with advanced or metastatic cancers, including melanoma, non-small cell lung cancer, colorectal cancer and other solid tumors.
Envisics is an innovative automotive technology company with a focus on heads up display (“HUD”) and solid-state LiDAR solutions. The company leverages its proprietary holographic technology platform to deliver best-in-class products to OEMs globally. Envisics is led by Dr. Jamie Christmas, a pioneer and thought leader in dynamic holography
Kashiv BioSciences was created from the merger of Adello Biosciences and Kashiv Pharma. Kashiv is a fully integrated biosciences company focused on developing innovative technologies, improved medicines, and lifecycle management products with platforms in drug delivery, 505(b)(2)s, Biosimilars and NCEs. Kashiv also offers contract research and development services to pharmaceutical clients in need of formulation and analytical development expertise and/or clinical supply manufacture. Kashiv is headquartered in Bridgewater, NJ.
Cue Health Inc. (“Cue”) is an ISO 13485 certified company focused on developing and manufacturing consumer and professional medical diagnostic products that can be used in clinical or at-home settings. Cue’s mission is to create tools that empower physicians and consumers by increasing their access to actionable health data. Cue’s first product, the Cue Health Monitoring System, is a connected diagnostic platform. The company is based in San Diego, CA.
Phil is a B2B2C platform that connects patients, pharmacies, prescribers, and manufacturers in the specialty prescription ecosystem. Phil builds software solutions and end-to-end services to power the $320B industry. As the market faces high costs and inefficiency, Phil aims to bring meaningful changes to patient care and the economy.
Founded in 2005 and headquartered in South Plainfield, New Jersey, Prolong Pharmaceuticals, LLC specializes in the engineering of novel biologics to treat anemias, cancers, and their debilitating comorbidities by leveraging the multi-faceted core attributes of PEGylation technology. The company is led by Dr. Abraham Abuchowski, the inventor of PEGylation, the most successful drug delivery technology in history, now responsible for more than $30 billion in drug sales worldwide.
